
Sumitomo Pharma Co Ltd
TSE:4506

Sumitomo Pharma Co Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
285
894
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Sumitomo Pharma Co Ltd hold over its rivals?
What risks and challenges
does Sumitomo Pharma Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Sumitomo Pharma Co Ltd.
Provide an overview of the primary business activities
of Sumitomo Pharma Co Ltd.
What unique competitive advantages
does Sumitomo Pharma Co Ltd hold over its rivals?
What risks and challenges
does Sumitomo Pharma Co Ltd face in the near future?
Summarize the latest earnings call
of Sumitomo Pharma Co Ltd.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Sumitomo Pharma Co Ltd.
Provide P/S
for Sumitomo Pharma Co Ltd.
Provide P/E
for Sumitomo Pharma Co Ltd.
Provide P/OCF
for Sumitomo Pharma Co Ltd.
Provide P/FCFE
for Sumitomo Pharma Co Ltd.
Provide P/B
for Sumitomo Pharma Co Ltd.
Provide EV/S
for Sumitomo Pharma Co Ltd.
Provide EV/GP
for Sumitomo Pharma Co Ltd.
Provide EV/EBITDA
for Sumitomo Pharma Co Ltd.
Provide EV/EBIT
for Sumitomo Pharma Co Ltd.
Provide EV/OCF
for Sumitomo Pharma Co Ltd.
Provide EV/FCFF
for Sumitomo Pharma Co Ltd.
Provide EV/IC
for Sumitomo Pharma Co Ltd.
Show me price targets
for Sumitomo Pharma Co Ltd made by professional analysts.
What are the Revenue projections
for Sumitomo Pharma Co Ltd?
How accurate were the past Revenue estimates
for Sumitomo Pharma Co Ltd?
What are the Net Income projections
for Sumitomo Pharma Co Ltd?
How accurate were the past Net Income estimates
for Sumitomo Pharma Co Ltd?
What are the EPS projections
for Sumitomo Pharma Co Ltd?
How accurate were the past EPS estimates
for Sumitomo Pharma Co Ltd?
What are the EBIT projections
for Sumitomo Pharma Co Ltd?
How accurate were the past EBIT estimates
for Sumitomo Pharma Co Ltd?
Compare the revenue forecasts
for Sumitomo Pharma Co Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Sumitomo Pharma Co Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Sumitomo Pharma Co Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Sumitomo Pharma Co Ltd compared to its peers.
Compare the P/E ratios
of Sumitomo Pharma Co Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Sumitomo Pharma Co Ltd with its peers.
Analyze the financial leverage
of Sumitomo Pharma Co Ltd compared to its main competitors.
Show all profitability ratios
for Sumitomo Pharma Co Ltd.
Provide ROE
for Sumitomo Pharma Co Ltd.
Provide ROA
for Sumitomo Pharma Co Ltd.
Provide ROIC
for Sumitomo Pharma Co Ltd.
Provide ROCE
for Sumitomo Pharma Co Ltd.
Provide Gross Margin
for Sumitomo Pharma Co Ltd.
Provide Operating Margin
for Sumitomo Pharma Co Ltd.
Provide Net Margin
for Sumitomo Pharma Co Ltd.
Provide FCF Margin
for Sumitomo Pharma Co Ltd.
Show all solvency ratios
for Sumitomo Pharma Co Ltd.
Provide D/E Ratio
for Sumitomo Pharma Co Ltd.
Provide D/A Ratio
for Sumitomo Pharma Co Ltd.
Provide Interest Coverage Ratio
for Sumitomo Pharma Co Ltd.
Provide Altman Z-Score Ratio
for Sumitomo Pharma Co Ltd.
Provide Quick Ratio
for Sumitomo Pharma Co Ltd.
Provide Current Ratio
for Sumitomo Pharma Co Ltd.
Provide Cash Ratio
for Sumitomo Pharma Co Ltd.
What is the historical Revenue growth
over the last 5 years for Sumitomo Pharma Co Ltd?
What is the historical Net Income growth
over the last 5 years for Sumitomo Pharma Co Ltd?
What is the current Free Cash Flow
of Sumitomo Pharma Co Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Sumitomo Pharma Co Ltd.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
JP |
![]() |
Sumitomo Pharma Co Ltd
TSE:4506
|
355.2B JPY | 1 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
767.8B USD | 17 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
372.4B USD | 4.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK | 6.8 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
214.2B CHF | 3.5 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
189.9B CHF | 4.4 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
164.5B GBP | 4 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
211.2B USD | 3.3 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD | 70.5 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
136.2B USD | 2.2 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
JP |
![]() |
Sumitomo Pharma Co Ltd
TSE:4506
|
Average P/S:
63.2
1
|
6%
|
0.2 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
17
|
23%
|
0.7 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
578.3
|
9%
|
64.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
4.2
|
4%
|
1 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
6.8
|
16%
|
0.4 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
3.5
|
5%
|
0.7 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
4.4
|
3%
|
1.5 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
4
|
7%
|
0.6 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
3.3
|
5%
|
0.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
70.5
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
2.2
|
-1%
|
N/A |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.